Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGLX
3751
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
| $23K | ﹤0.01% |
+44,800
| New | +$21.4K |
|
|
SQZ
3752
DELISTED
SQZ Biotechnologies Company
SQZ
| $23K | ﹤0.01% |
83,603
+9,300
| +13% | +$5.28K |
|
|
NVIV
3753
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
| $23K | ﹤0.01% |
17,266
+6,241
| +57% | +$7.94K |
|
3754
Aclarion
ACON
$5.71M
| – | – |
0
| – | – |
|
|
ADIL
3755
Adial Pharmaceuticals
ADIL
$9.43M
| $22K | ﹤0.01% |
171
+10
| +6% | +$1.81K |
|
3756
Cineverse
CNVS
$68.9M
| $22K | ﹤0.01% |
11,363
-217
| -2% | -$1.3K |
|
3757
China Pharma Holdings
CPHI
$46.6M
| $22K | ﹤0.01% |
1,277
-2,130
| -63% | -$37.4K |
|
|
FLNT
3758
Fluent
FLNT
$129M
| $22K | ﹤0.01% |
5,750
+400
| +7% | +$1.68K |
|
3759
IceCure Medical
ICCM
$10.6M
| $22K | ﹤0.01% |
+630
| New | +$22.6K |
|
|
PTN
3760
Palatin Technologies
PTN
$16.8M
| $22K | ﹤0.01% |
211
-16
| -7% | -$1.9K |
|
3761
Twin Vee PowerCats
VEEE
$7.14M
| $22K | ﹤0.01% |
29
-63
| -68% | -$38.8K |
|
3762
Anghami
ANGH
$34.6M
| $21K | ﹤0.01% |
+1,830
| New | +$23.9K |
|
|
EM
3763
DELISTED
Smart Share Global Ltd
EM
| $21K | ﹤0.01% |
+22,000
| New | +$20.9K |
|
3764
FGI Industries
FGI
$9.13M
| $21K | ﹤0.01% |
+2,420
| New | +$21.8K |
|
3765
iSpecimen
ISPC
$3.26M
| $21K | ﹤0.01% |
+19
| New | +$22.2K |
|
3766
Nephros
NEPH
$47.4M
| $21K | ﹤0.01% |
13,705
-9,495
| -41% | -$14K |
|
3767
Ostin Technology Group
OST
| $21K | ﹤0.01% |
104
-114
| -52% | -$28.9K |
|
3768
Meiwu Technology Co
WNW
$70M
| $20K | ﹤0.01% |
2
+1
| +100% | +$13.3K |
|
|
SFE
3769
DELISTED
Safeguard Scientifics, Inc.
SFE
| $20K | ﹤0.01% |
12,000
+1,400
| +13% | +$2.44K |
|
|
LFLY
3770
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
| $20K | ﹤0.01% |
3,430
+410
| +14% | +$2.78K |
|
3771
New Concept Energy
GBR
$3.69M
| $19K | ﹤0.01% |
15,500
-1,900
| -11% | -$2.06K |
|
|
IMCC
3772
IM Cannabis
IMCC
$1.17M
| $19K | ﹤0.01% |
+3,383
| New | +$17.6K |
|
|
INCR
3773
Intercure
INCR
$57.1M
| $19K | ﹤0.01% |
11,200
-33,487
| -75% | -$73.3K |
|
3774
Newegg Commerce
NEGG
$415M
| $19K | ﹤0.01% |
+796
| New | +$18K |
|
3775
Precipio
PRPO
$40.3M
| $19K | ﹤0.01% |
2,452
+495
| +25% | +$5.6K |
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 541 new positions and closed 599 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.